Medical devices, healthcare technology and the business of care
PMA approval · P030004

ONYX LIQUID EMBOLIC SYSTEM

Ev3 Neurovascular · Decision date Jul 21, 2005

MEDTECHLEDGER EXPLANATIONP030004

What did the FDA approve?

The FDA recorded approval of premarket application P030004 for the Onyx Liquid Embolic System, submitted by Ev3 Neurovascular, on 2005-07-21. The product is classified as an injectable embolic agent under product code MFE, in the neurology specialty. The approval statement describes the device as indicated for presurgical embolization of brain arteriovenous malformations, a scope attributed to the 2005 decision and not asserted here as current labeling.

This is an original approval rather than a supplement, so no changed component or modified item is recorded in the source. Details of device composition, delivery components, patient-selection criteria, dosing and procedural instructions are not present in the available record and would reside in the original FDA documents, which were not supplied. No clinical or comparative conclusions are drawn.

FDA approval order statement

APPROVAL FOR THE ONYX LIQUID EMBOLIC SYSTEM (LES). THE DEVICE IS INDICATED FOR PRESURGICAL EMBOLIZATION OF BRAIN ARTERIOVENOUS MALFORMATIONS.
Regulatory pathway
Original PMA
Clinical specialty
Neurology
Decision date
Jul 21, 2005

FDA source record · MedtechLedger’s explanation describes the recorded change.

Regulatory record facts

Identifier
P030004
Regulatory pathway
Premarket approval application
Product code
MFE
Decision code
APPR
Decision date
Jul 21, 2005
Source update
Nov 9, 2026
Original record
Open FDA source record

About this medical device

FDA device category: Agent, injectable, embolic.

Product code
MFE
FDA device class
3

The approval statement above describes the scope recorded for this original decision. Later supplements may change the device or its indications.

FDA decision timeline

  1. P030004 received

    Application receipt date recorded by FDA.

  2. P030004 · FDA decision

    APPR

  3. P030004/S039 · Related supplement

    Onyx Liquid Embolic System (Onyx LES)

Timeline entries are records held by MedtechLedger for P030004. View FDA’s full supplement list.

Related devices and submissions

Same PMA: P030004

Product / regulatory recordCompanyPathwayDecision dateSource
Ev3 NeurovascularPMA supplementOct 14, 2026FDA

Explore the linked device profile

Regulatory context

An original PMA is a premarket approval application. The recorded approval scope is described in FDA’s order and supporting documents.

Read our guide to FDA clearance and approval · FDA’s explanation of this pathway

Manufacturer intelligence

Ev3 Neurovascular

Headquarters
Not reported
Brand website
Not reported
FDA applicant address
9775 Toledo Way, Irvine, CA, 92618

Sources and methodology

FDA fields and approval-order wording are presented as source information. MedtechLedger explanations are identified separately and describe the scope of the recorded decision. Indications from an original PMA are historical unless confirmed against subsequent labeling and supplements.

How we use FDA records